Viewing Study NCT05474560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-05-25 @ 2:48 AM
Study NCT ID: NCT05474560
Status: COMPLETED
Last Update Posted: 2023-08-01
First Post: 2022-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients
Sponsor: Ain Shams University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Alcoholic Fatty Liver Disease View
None Hyperuricemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Allopurinol View
None Febuxostat View
None Fatty liver disease View
None Hyperuricemia View